Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01402453 · ClinicalTrials.gov registry record · NA

Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT01402453 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 207 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01402453, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

Despite unequivocal proof that tight control of blood pressure with antihypertensive medication can prevent hypertensive complications-including strokes, myocardial infarcts, heart failure, end-stage renal disease, and death- blood pressure remains uncontrolled in the majority of individuals with hypertension. We propose a novel patient-centered intervention that combines monetary incentives and a social psychological intervention to help patients sustain blood pressure control once incentives are no longer offered by strengthening intrinsic motivation to control blood pressure among two vulnerable populations: African Americans, who suffer disproportionately from hypertension, and Mexican Americans, who have the lowest hypertension control rates of any demographic group in the United States. If the intervention is successful, it could be adapted as a set of tools to apply in clinical practice to improve outcomes of a range of chronic diseases, by maximizing the motivation of patients to optimize their treatment.

Interventions

  • BEHAVIORAL Monetary Incentives
  • BEHAVIORAL Intrinsic Motivation

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2011-08
Est. Completion 2013-09
Phase NA

What the Registry Record Tells You About NCT01402453

The ClinicalTrials.gov registry entry for NCT01402453 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Monetary Incentives is the first listed.

NCT01402453 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01402453 about?

NCT01402453 is a clinical study titled "Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control". Despite unequivocal proof that tight control of blood pressure with antihypertensive medication can prevent hypertensive complications-including strokes, myocardial infarcts, heart failure, end-stage renal disease, and death- blood pressure remains uncontrolled in the majority of individuals with hy...

What is the current status of trial NCT01402453?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2011-08. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01402453?

The interventions under investigation include: Monetary Incentives (BEHAVIORAL), Intrinsic Motivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01402453?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.